BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON Share Price

Certificat

S35560

DE000SW9K5H3

Market Closed - Borsa Italiana 12:28:12 28/06/2024 pm IST
1.05 EUR +3.24% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON
Current month-15.39%
1 month-19.48%
Date Price Change
28/24/28 1.05 +3.24%
27/24/27 1.017 -11.10%
26/24/26 1.144 -1.38%
25/24/25 1.16 -15.70%
24/24/24 1.376 +4.80%

Real-time Borsa Italiana

Last update June 28, 2024 at 12:28 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
S35560
ISINDE000SW9K5H3
Date issued 30/04/2024
Strike 135.4 $
Maturity Unlimited
Parity 10 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.89
Lowest since issue 0.878
Spread 0.06
Spread %5.60%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.8 USD
Average target price
171.7 USD
Spread / Average Target
+17.78%
Consensus
  1. Stock Market
  2. Certificates
  3. S35560 Certificat